Hearts and Minds Investments (HM1) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
3 Feb, 2026Opening remarks and agenda
The meeting was opened with a quorum present, welcoming both in-person and online shareholders, and introducing the board, executives, and auditors.
The hybrid format enabled broad participation, with clear instructions for questions and voting provided to all attendees.
Financial performance review
Portfolio increased by 11.7% for the year ended 30 June 2024, with a 32% return for the year to 31 October 2024 and a 10.7% annualized return since inception.
Share price rose from $2.26 to $2.58 over FY24, with total shareholder returns of 20% and the share price discount to NTA narrowing to 12%.
Technology holdings and the 2023 conference portfolio were key drivers of performance; Munro Partners' addition as a core manager had a positive impact.
Guzman y Gomez IPO delivered a 134% return since investment; Rokt pre-IPO position is held at cost.
Board and executive committee updates
Directors and key executives were introduced, with the board focused on sustaining investment performance and shareholder engagement.
Munro Partners joined as a new core fund manager, contributing to improved results.
Latest events from Hearts and Minds Investments
- Flat portfolio returns and a major write-down led to a sharp drop in half-year profit.HM1
H1 202617 Feb 2026 - Strong returns, rising dividends, and major medical research funding highlighted at AGM.HM1
AGM 202526 Nov 2025 - FY25 saw a 25.5% pre-tax return, 24% shareholder return, and $9.5M donated to medical research.HM1
H2 202528 Aug 2025 - Strong investment gains, higher dividends, and robust returns drive improved FY24 results.HM1
H2 202413 Jun 2025 - Record half-year profit and robust portfolio returns drive NTA and dividend growth.HM1
H1 20255 Jun 2025